CanadianSME Small Business Podcast

Can Bitcoin Secure the Future of Canadian SMEs?

Episode Notes

Welcome to the CanadianSME Small Business Podcast, hosted by Kripa Anand, where we explore innovations shaping Canadian business. 

Today, we’re diving into the intersection of biotechnology and financial strategy with Akeem Gardner, CEO & Founder of Canurta Therapeutics. Akeem is pioneering a fresh approach in the biotech space, using hemp cultivation for botanical solutions to inflammation while navigating the challenges of underfunded R&D.

We’ll discuss Canurta's innovative model, The Satoshi Trials, and how Bitcoin can serve as a financial tool for research-intensive SMEs. Akeem will also share practical guidance for Canadian small businesses looking to adopt Bitcoin and explore its potential for fostering financial resilience. Let’s dive in!

Key Highlights:

1. Redefining Biotech R&D in Canada: Akeem will explain why R&D spending is risky for Canadian SMEs in biotech and how Canurta is developing next-generation botanical therapeutics for diseases like ALS and inflammation.

2. The Satoshi Trials – Bitcoin as a Financial Tool for SMEs: Akeem will discuss how The Satoshi Trials connect Bitcoin to solving real-world challenges in business growth for biotech and other research-intensive SMEs.

3. Practical Bitcoin Adoption for Canadian SMEs & Future-Proofing: Akeem will provide guidance on how Canadian SMEs can adopt Bitcoin today to strengthen operations and future-proof against economic uncertainties.

4. Recent Accomplishments Highlight: Akeem will share Canurta's achievements, including FDA feedback for clinical trials, graduating from CDL, being accepted into MATTER Health, and preparing for a public listing.

Special Thanks to Our Partners:

For more expert insights, visit www.canadiansme.ca and subscribe to the CanadianSME Small Business Magazine. Stay innovative, stay informed, and thrive in the digital age!

Disclaimer: The information shared in this podcast is for general informational purposes only and should not be considered as direct financial or business advice. Always consult with a qualified professional for advice specific to your situation.